BL P 1322,
BL-P 1322,
BLP 1322,
Brisfirina,
Céfaloject,
Cefadyl,
Cefapirin,
Cephapirin,
Cephapirin Monosodium Salt,
Cephapirin Sodium,
Cephapirin, Sodium,
Monosodium Salt, Cephapirin,
Salt, Cephapirin Monosodium,
Sodium Cephapirin,
CEPHAPIRIN SODIUM,
cefapirin sodium,
Sodium cefapirin,
24356-60-3,
Sodium cephapirin,
UNII-431LFF7I7J,
Cefatrexyl,
Ambrocef,
Cefadyl,
Cefatrex,
Cefapirin sodium salt,
Sodium 7-(pyrid-4-ylthioacetamido)cephalosporanate,
Cephapirin sodium salt,
Brisfirina,
Cephatrexyl,
Brisporin,
Bristocef,
431LFF7I7J,
CHEBI:3545,
Cefadyl IM/IV,
BL-P-1322,
Cefa-Lak (Veterinary),
BLP 1322,
7-(alpha-(4-Pyridylthio)acetamido)cephalosporanic acid sodium salt,
Antibiotic BL-P 1322,
BL-P 1322,
DSSTox_CID_25574,
DSSTox_RID_80971,
DSSTox_GSID_45574,
EINECS 246-194-2,
ANTIBIOTIC BL-P1322,
Cefapirina sodica,
NSC 179171,
(7R,7aR)-3-(acetyloxymethyl)-6-oxo-7-(2-(4-pyridylthio)acetylamino)-2H,7H-azet idino[2,1-b]1,3-thiazine-4-carboxylic acid, sodium salt,
3-[(Acetyloxy)methyl]-8-oxo-7-{(4-pyridinylthio)acetyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid monosodium salt,
Sodium (6R-trans)-3-(acetoxymethyl)-8-oxo-7-((4-pyridylthio)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate,
356C603,
Cephapirin sodium [USAN:USP],
Prestwick_27,
NCGC00017093-01,
Monosodium (6R,7R)-3-(hydroxymethyl)-8-oxo-7-(2-(4-pyridylthio)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate acetate (ester),
Cefadyl (TN),
CAS-24356-60-3,
Cefapirin sodium (JAN),
Cephapirin sodium (USP),
Cephapirin sodium, >=96%,
SCHEMBL64430,
SPECTRUM1500167,
CHEMBL1201043,
DTXSID7045574,
HMS500C04,
HMS1570L03,
HMS1920K13,
HMS2091A16,
5-Thia-1-azabicyclo(4,2,0)oct-2-ene-2-carboxylic acid, 3-(hydroxymethyl)-8-oxo-7-(2-(4-pyridylthio)acetamido)-, acetate (ester), monosodium salt,
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-(((4-pyridylthio)acetyl)amino)-, monosodium salt, (6R-trans)-,
sodium;(6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-pyridin-4-ylsulfanylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,
Tox21_110772,
CCG-38912,
Cefapirin sodium, analytical standard,
AKOS024282660,
AKOS032953845,
Tox21_110772_1,
API0000458,
NCGC00093735-01,
NCGC00162116-04,
ST057376,
EU-0100279,
FT-0603005,
C 8270,
C08101,
D00908,
Cefapirin sodium, European Pharmacopoeia (EP) Reference Standard,
Cephapirin sodium, United States Pharmacopeia (USP) Reference Standard,
(6R,7R)-3-[(Acetyloxy)methyl]-8-oxo-7-[[(4-pyridinylthio)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium,
(6R-trans)-3-((acetyloxy)methyl)-8-oxo-7-(((4-pyridylthio)acetyl)amino)-5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monosodium salt,
monosodium (6R,7R)-3-(hydroxymethyl)-8-oxo-7-(2-(4-pyridylthio)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate acetate,
Sodium (6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-pyridin-4-ylsulfanylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,
sodium (6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-{[(pyridin-4-ylsulfanyl)acetyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,
Cefaloject,
Cephatrexil,
cephapirin,
ToDay,
Cefa lak,
Cefapirinsodium,
Cela-Lak/ToDay,
CEPR,
Cephapirin sodium [USAN],
C17H16N3NaO6S2,
C17H17N3O6S2.Na,
CID441388,
C17-H16-N3-Na-O6-S2,
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-(hydroxymethyl)-8-oxo-7-[2-(4-pyridylthio)acetamido]-, acetate (ester), monosodium salt,
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[[(4-pyridinylthio)acetyl]amino]-, monosodium salt, (6R,7R)-,
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[[(4-pyridinylthio)acetyl]amino]-, monosodium salt, (6R-trans)-,
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[[(4-pyridinylthio)acetyl]amino]-,monosodium salt, (6R-trans)-,
Sodium (6R-trans)-3-(acetoxymethyl)-8-oxo-7-[(4-pyridylthio)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,